No products in the cart.
LENVIMA 4 Mg (LENVATINIB 4 mg)
LENVIMA 4 mg is a targeted cancer therapy used in the treatment of thyroid, kidney, and liver cancers. Contains Lenvatinib, a tyrosine kinase inhibitor.
LENVIMA 4 Mg (LENVATINIB 4 mg)
| Active Ingredient | Lenvatinib |
|---|---|
| Manufacturers | Eisai Pharmaceuticals India Pvt. Ltd |
| Indications | Thyroid cancer |
| Strength | 4mg |
| Packaging | 10 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
LENVIMA 4 mg contains Lenvatinib, a prescription anti-cancer medicine used for the treatment of advanced or metastatic cancers, including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer). It works as a tyrosine kinase inhibitor (TKI) by blocking the signals that cancer cells need to grow and spread.
Lenvima 4 mg is often prescribed as part of a combination therapy or for patients who do not respond to radioactive iodine treatment (in thyroid cancer cases). The treatment is taken orally and requires regular medical supervision, as it can affect blood pressure, liver function, and other vital parameters.
Warning: Use this medicine only under the guidance of a cancer specialist. Dosage varies by cancer type and patient condition.
| pack size | 10 Capsules – USD $16.40/ Capsule, 20 Capsules – USD $14.95/ Capsule, 30 Capsules – USD $14.27/ Capsule |
|---|
Be the first to review “LENVIMA 4 Mg (LENVATINIB 4 mg)”
You must be logged in to post a review.
Related Products
Buy Tamoxifen 10 Mg (Tamoxifen)
Price range: $25.00 through $57.00
Buy Geftinat 250Mg (Gefitinib)
Price range: $309.00 through $999.00
Buy Imat 400 Mg (Imatinib)
Price range: $130.00 through $375.00
Buy Aromasin 25 Mg (Exemestane)
Price range: $95.00 through $323.00
There are no reviews yet.